Neuromelanin-Sensitive MRI as Candidate Marker for Treatment Resistance in First-Episode Schizophrenia

van der Pluijm, M., Wengler, K., Reijers, P. N., Cassidy, C. M., Tjong Tjin Joe, K., de Peuter, O. R., Horga, G., Booij, J., de Haan, L., & van de Giessen, E. (2024). Neuromelanin-Sensitive MRI as Candidate Marker for Treatment Resistance in First-Episode Schizophrenia. American Journal of Psychiatry, 181(6), 512–519. https://doi.org/10.1176/appi.ajp.20220780
Authors:
Marieke van der Pluijm
Kenneth Wengler
Pascalle N Reijers
Clifford M Cassidy
Kaithlyn Tjong Tjin Joe
Olav R de Peuter
Guillermo Horga
Jan Booij
Lieuwe de Haan
Elsmarieke van de Giessen
Affiliated Authors:
Marieke van der Pluijm
Kenneth Wengler
Pascalle N Reijers
Clifford M Cassidy
Kaithlyn Tjong Tjin Joe
Olav R de Peuter
Guillermo Horga
Jan Booij
Lieuwe de Haan
Elsmarieke van de Giessen
Columbia Affiliation:
Subjects:
Melanins (MeSH)
Magnetic Resonance Imaging (MeSH)
Substantia Nigra (MeSH)
Antipsychotic Agents (MeSH)
Biomarkers (MeSH)
Author Keywords:
first-episode psychosis
mri
neuroimaging
neuromelanin
schizophrenia spectrum and other psychotic disorders
treatment-resistant schizophrenia
elink
Publication Type:
Article
Unique ID:
10.1176/appi.ajp.20220780
PMID:
38476044
DOI:
10.1176/appi.ajp.20220780
Journal:
American Journal of Psychiatry
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: